Artwork

Content provided by Audacy. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Audacy or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Jimmy Fund Interview - Kadidia Dienta and Dr. Reid Merryman

7:45
 
Share
 

Manage episode 434010035 series 2447275
Content provided by Audacy. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Audacy or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Kadidia Dienta joins Gresh and Fauria along with Dr. Reid Merryman. Kadidia discusses her battle with lymphoma cancer that begin in July 2020. Kadidia’s treatment included chemotherapy, CAR T therapy, and after two relapses with cancer, she is currently participating in a clinical trial that shows promise.

Dr. Merryman is an attending physician in the Lymphoma Program at Dana-Farber Cancer Institute. His research focuses on the development of immune-based therapies for patients with lymphoma.

  continue reading

510 episodes

Artwork
iconShare
 
Manage episode 434010035 series 2447275
Content provided by Audacy. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Audacy or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Kadidia Dienta joins Gresh and Fauria along with Dr. Reid Merryman. Kadidia discusses her battle with lymphoma cancer that begin in July 2020. Kadidia’s treatment included chemotherapy, CAR T therapy, and after two relapses with cancer, she is currently participating in a clinical trial that shows promise.

Dr. Merryman is an attending physician in the Lymphoma Program at Dana-Farber Cancer Institute. His research focuses on the development of immune-based therapies for patients with lymphoma.

  continue reading

510 episodes

Усі епізоди

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide